Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $16.2 million.

  • Lucid Diagnostics' Net Cash Flow rose 25539.26% to $16.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year increase of 44351.01%. This contributed to the annual value of $3.5 million for FY2024, which is 19675.8% up from last year.
  • Per Lucid Diagnostics' latest filing, its Net Cash Flow stood at $16.2 million for Q3 2025, which was up 25539.26% from $5.9 million recorded in Q2 2025.
  • Lucid Diagnostics' 5-year Net Cash Flow high stood at $17.0 million for Q1 2023, and its period low was -$15.2 million during Q2 2022.
  • Its 4-year average for Net Cash Flow is -$421600.0, with a median of -$4.5 million in 2022.
  • As far as peak fluctuations go, Lucid Diagnostics' Net Cash Flow crashed by 6555.02% in 2024, and later soared by 382052.98% in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Net Cash Flow stood at -$4.5 million in 2022, then decreased by 15.56% to -$5.2 million in 2023, then soared by 252.68% to $7.9 million in 2024, then surged by 105.99% to $16.2 million in 2025.
  • Its last three reported values are $16.2 million in Q3 2025, $5.9 million for Q2 2025, and $2.8 million during Q1 2025.